Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

HIV Infections (Disease Or Phenotype)

Nci:C3108

Msh:D015658

Mondo:MONDO:5109

Medcin:MEDCIN:90240

Mdr:MDR:10020172

Id:a4abc8f8-3f78-5124-98ce-c802f1935a36

Icpc2icd10eng:MTHU000680

Icd10cm:B20-B20

Efo:EFO:764

Doid:DOID:526

Chv:CHV:6188

Results found

Linked to

	Label	Description
	Tenofovir alafenamide indication HIV Infections Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Rilpivirine indication HIV Infections Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(S)-1-[(S)-2-Hydroxy-4-((R)-(R)-2-hydroxy-indan-1-ylcarbamoyl)-5-(S)-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide indication HIV Infections Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Cobicistat indication HIV Infections Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-(2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide indication HIV Infections Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Tipranavir indication HIV Infections Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide indication HIV Infections Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Amprenavir indication HIV Infections Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Enfuvirtide indication HIV Infections Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Didanosine indication HIV Infections Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Tenofovir alafenamide indication HIV Infections

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Rilpivirine indication HIV Infections

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(S)-1-[(S)-2-Hydroxy-4-((R)-(R)-2-hydroxy-indan-1-ylcarbamoyl)-5-(S)-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide indication HIV Infections

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Cobicistat indication HIV Infections

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

N-(2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide indication HIV Infections

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Tipranavir indication HIV Infections

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide indication HIV Infections

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Amprenavir indication HIV Infections

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Enfuvirtide indication HIV Infections

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Didanosine indication HIV Infections

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.